3.
同时用药组、先重组人血管内皮抑素组与模型组治疗前、后瘤体积变化比较
Comparison of the changes of tumor volume during therapy among the concurrent administration group, endo-first group and model group (Mean±SD, n=8)
| Group | Tumor volume (mm3) | Difference (mm3) | P | Inhibitory rate of tumor volume (%) | |
| Pre-therapy | Post-therapy | ||||
| Concurrent administration | 7.14±2.58 | 66.55±41.25 | 59.40±41.52 | 0.175a | 73.71 |
| Endo-first | 7.30±2.51 | 116.99±77.40 | 109.46±76.87 | 0.003b | 51.55 |
| Model | 7.74±2.57 | 233.67±87.80 | 225.93±86.97 | 0.000c | 0 |